BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Aug 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-08-06

Reporting Person: LEWIS ALAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-06	Common Stock	M	30000	$14.21	Acquired	55900	Direct
2012-08-06	Common Stock	S	40000	$37.5689	Disposed	15900	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-06	Stock Option (right to buy) Common Stock	$14.21	M	30000	Disposed	2016-06-27	Common Stock (30000)	Direct

Footnotes

F1: The range of sales prices received was $37.22 to $37.98. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

F2: Options vest 1/4th each on September 28, 2006, December 28, 2006, March 28, 2007 and June 28, 2007.